PD-L1 binds to the programmed death-1 (PD-1) and B7.1 (CD80) proteins, and this binding can inhibit the killing of tumor cells by the immune system and decrease T-cell activation, migration, and proliferation [1, 2]. Here, CD80 is linked to neoplasm.